You have 9 free searches left this month | for more free features.

Mastocytosis

Showing 1 - 25 of 104

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

A Registry for Patients With Systemic Mastocytosis in China

Not yet recruiting
  • Systemic Mastocytoses
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University, Jiangsu Ins
    Aug 24, 2023

    Quality of Life and Disease-related Symptoms in Individuals With

    Not yet recruiting
    • Mastocytosis, Systemic
    • No intervention
    • Stockholm, Sweden
    • +1 more
    Sep 26, 2023

    DALY on a Cohort of Patients With Indolent Systemic Mastocytosis

    Recruiting
    • Mastocytosis, Indolent Systemic
      • Toulouse, Haute-Garonne, France
        Centre de Référence des Mastocytoses, Service de Dermatologie, H
      Jun 19, 2023

      Advanced Systemic Mastocytosis Trial (BLU-263, Azacitidine)

      Not yet recruiting
      • Advanced Systemic Mastocytosis
      • (no location specified)
      Nov 2, 2022

      Aggressive Systemic Mastocytosis, Systemic Mastocytosis-associated Hematologic Non-mast Cell Disease, Mast Cell Leukemia Trial

      Completed
      • Aggressive Systemic Mastocytosis
      • +3 more
      • Stanford, California
      • +10 more
      Jan 12, 2023

      Systemic Mastocytosis With AHNMD, Acute Myeloid Leukemia With T(8;21)(Q22;Q22) Trial in Suzhou

      Not yet recruiting
      • Systemic Mastocytosis With AHNMD
      • Acute Myeloid Leukemia With T(8;21)(Q22;Q22)
        • Suzhou, Jiangsu, China
          The First Affiliated Hospital of Soochow University, Jiangsu Ins
        Aug 16, 2022

        Study of Factors Regulating Mast Cell Proliferation

        Recruiting
        • Mastocytosis
        • +3 more
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Feb 2, 2023

          Study of Mast Cell Precursors

          Completed
          • Mastocytosis
          • Healthy Volunteer
            • Bethesda, Maryland
              National Institutes of Health Clinical Center
            Nov 4, 2022

            SSM, Mastocytosis, Indolent, Mastocytosis, Systemic Trial in United States (CGT9486 Tablets, Placebo Tablets)

            Recruiting
            • SSM
            • +3 more
            • CGT9486 Tablets
            • Placebo Tablets
            • Clearwater, Florida
            • +5 more
            Apr 14, 2022

            Mast Cell Activation Disease, Mast Cell Activation Syndrome, Mast Cell Disease Trial in Poitiers (Ophthalmological examination)

            Recruiting
            • Mast Cell Activation Disease
            • +3 more
            • Ophthalmological examination
            • Poitiers, Nouvelle Aquitaine, France
              Masson Regnault
            Apr 12, 2022

            Advanced Systemic Mastocytosis (AdvSM), SM With an Associated Hematologic Tumor (SM-AHN), Mast Cell Leukemia (MCL) Trial in

            Recruiting
            • Advanced Systemic Mastocytosis (AdvSM)
            • +3 more
            • CGT9486 tablets
            • Duarte, California
            • +10 more
            Jul 8, 2022

            Cutaneous Mastocytoses Trial in Rochester (Topical preparation of sodium cromolyn 5%, diphenhydramine 1% and trolamine

            Recruiting
            • Cutaneous Mastocytoses
            • Topical preparation of sodium cromolyn 5%, diphenhydramine 1% and trolamine salicylate 10% in emollient cream base.
            • Rochester, Minnesota
              Mayo Clinic in Rochester
            Mar 11, 2022

            Mastocytosis Trial in Toulouse (Hydroxychloroquine)

            Not yet recruiting
            • Mastocytosis
            • Toulouse, France
              Larrey Hospital - Toulouse University Hospital
            Oct 6, 2021

            High-risk MDS, Acute Myelogenous Leukemia, Systemic Mastocytosis Trial in Minneapolis, Madison (GTB-3550 TriKE® Phase I,

            Terminated
            • High-risk Myelodysplastic Syndromes
            • +3 more
            • GTB-3550 TriKE® Phase I
            • GTB-3550 TriKE® Phase II
            • Minneapolis, Minnesota
            • +1 more
            Mar 21, 2022

            Chronic Myelomonocytic Leukemia, Chronic Myeloid Leukemia, Polycythemia Vera Trial in Houston (Imatinib Mesylate (Gleevec))

            Completed
            • Chronic Myelomonocytic Leukemia
            • +4 more
            • Imatinib Mesylate (Gleevec)
            • Houston, Texas
              UT MD Anderson Cancer Center
            Dec 7, 2021

            Pregnancy and Medically Assisted Conception in Rare Diseases

            Recruiting
            • Rheumatoid Arthritis
            • +10 more
              • Paris, France
                Hôpital Cochin
              Oct 31, 2022

              Indolent Systemic Mastocytosis Trial in France, Germany, United States (Masitinib, Placebo, Best Supportive Care)

              Recruiting
              • Indolent Systemic Mastocytosis
              • Rochester, Minnesota
              • +6 more
              Nov 29, 2021

              Avapritinib Versus Best Available Therapy in Patients With AdvSM

              Completed
              • Advanced Systemic Mastocytosis
              • +3 more
                • Palo Alto, California
                • +5 more
                Dec 17, 2021

                Advanced Systemic Mastocytosis, Aggressive Systemic Mastocytosis, Systemic Mastocytosis With an Associated Hematological Tumor

                Approved for marketing
                • Advanced Systemic Mastocytosis
                • +3 more
                • (no location specified)
                Oct 5, 2021

                Leukemia, Acute Myeloid, MDS, Classical Hodgkin Lymphoma Trial in United States (MGD024)

                Recruiting
                • Leukemia, Acute Myeloid
                • +7 more
                • Denver, Colorado
                • +4 more
                Aug 29, 2022

                Advanced Systemic Mastocytosis, Aggressive Systemic Mastocytosis, Systemic Mastocytosis With an Associated Hematologic Tumor

                Active, not recruiting
                • Advanced Systemic Mastocytosis
                • +3 more
                • Stanford, California
                • +31 more
                Mar 25, 2022

                Indolent Systemic Mastocytosis, Monoclonal Mast Cell Activation Syndrome Trial in Worldwide (BLU-263, Placebo)

                Recruiting
                • Indolent Systemic Mastocytosis
                • Monoclonal Mast Cell Activation Syndrome
                • Palo Alto, California
                • +33 more
                Jul 27, 2022

                Mast Cell Activation Syndrome in EDS With Digestive Disorders

                Recruiting
                • Ehlers Danlos Hypermobile Syndrome
                • Determine the presence of mast cell activation syndrome
                • Lille, Nord, France
                  Saint-Vincent-de-Paul hospital
                Jan 10, 2023

                Primary Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia Trial in Toronto (Observational)

                Recruiting
                • Primary Myelofibrosis
                • +9 more
                • Observational
                • Toronto, Ontario, Canada
                  Princess Margaret Cancer Centre
                Apr 11, 2022

                Recurrent Acute Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Blastic Plasmacytoid Dendritic Cell Tumor Trial in

                Recruiting
                • Recurrent Acute Leukemia
                • +16 more
                • Duarte, California
                  City of Hope Medical Center
                Nov 22, 2022